Bain Capital Specialty Finance, INC

Market Movers (8-K)

NYSE
Bain Capital Specialty Finance, Inc. announced it will release its second quarter 2026 financial results on August 10, 2026, followed by a conference call on August 11, 2026.
NYSE
Bain Capital Specialty Finance, Inc. successfully re-elected three Class I directors and ratified its independent auditor at the 2026 Annual Meeting.
NYSE
Bain Capital Specialty Finance, Inc. announced it will release its first quarter 2026 financial results on May 11, 2026, followed by a conference call on May 12, 2026.
NYSE
Bain Capital Specialty Finance, Inc. announced strong financial results for the fourth quarter and full year ended December 31, 2025, and declared a first quarter 2026 dividend of $0.42 per share.
Capital raise
NYSE
Bain Capital Specialty Finance, Inc. announced it will release its fourth-quarter and fiscal year 2025 financial results on February 26, 2026, followed by a conference call.
NYSE
Bain Capital Specialty Finance, Inc. has issued $350 million in 5.950% notes due 2031, with proceeds intended for debt repayment and general corporate purposes.
Capital raise

Quarterly Earnings (10-Q)

NYSE
Bain Capital Specialty Finance, Inc. reports on its Q1 2026 financial performance, detailing investment activities and financial condition.
Capital raise
Worse than expected
NYSE
Bain Capital Specialty Finance reports a decrease in net assets and net investment income for Q3 2025, driven by lower investment income and net realized losses.
Worse than expected
Capital raise
NYSE
Bain Capital Specialty Finance, Inc. reported a decrease in net investment income and net assets from operations for the second quarter and first half of 2025, alongside a rise in non-accrual investments.
Worse than expected
Capital raise
NYSE
Bain Capital Specialty Finance files its 10-Q report, detailing investment activities and financial results for the quarter ended March 31, 2025.
Worse than expected
Capital raise
NYSE
Bain Capital Specialty Finance's latest 10-Q filing provides a detailed overview of its investment portfolio, financial condition, and operational results for the third quarter of 2024.
Worse than expected
NYSE
Bain Capital Specialty Finance's 10-Q filing details its investment portfolio as of June 30, 2024, including various loans, equity interests, and forward currency exchange contracts.

Annual Reports (10-K)

NYSE
Bain Capital Specialty Finance reports a decrease in net investment income and a net realized loss in 2025, alongside portfolio growth and strategic debt refinancing.
Worse than expected
Capital raise
NYSE
Bain Capital Specialty Finance's 10-K filing details the company's investment activities, financial condition, and adherence to regulatory standards for the fiscal year ended December 31, 2024.
NYSE
Bain Capital Specialty Finance's 10-K filing details its investment portfolio, financial performance, and strategic approach for the year ended December 31, 2023.
Worse than expected
Capital raise

Insider Trading (Form 4)

NYSE
Bain Capital Specialty Finance, Inc.'s General Counsel, Sabrina Rusnak-Carlson, acquired 2,300 shares of common stock at $12.55 per share.
NYSE
Director Clare Stack Richer purchased 1,530 shares of Bain Capital Specialty Finance (BCSF) at $16.43 per share on March 17, 2025, increasing her direct holdings to 20,834.77 shares.

Proxy Statements (Def-14A)

NYSE
Bain Capital Specialty Finance, Inc. has issued its 2026 proxy statement for the annual meeting of stockholders to be held on May 21, 2026.
NYSE
Bain Capital Specialty Finance is holding its annual stockholder meeting to elect directors and seek authorization to sell shares below net asset value.
Capital raise
NYSE
Bain Capital Specialty Finance files an amendment to its proxy statement clarifying the effect of broker non-votes on proposals to be voted on at the 2024 Annual Meeting of Stockholders.
NYSE
Bain Capital Specialty Finance is holding its annual meeting to elect directors, seek authorization for below-NAV share issuance, and approve potential meeting adjournment.
Capital raise

Schedule 13G - Passive Investments

NYSE
Bank of America Corp. has disclosed a beneficial ownership of 4.3% in Bain Capital Specialty Finance, Inc., holding 2,790,980 shares as of March 31, 2026.